MedTrace Logo

Value of Various Chemokines in the Detection and Follow up of RCC

NCT02022787 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2015-03-05

No results posted yet for this study

Summary

This study was designed as a pilot study to try and find a Chemokine that may be specific for renal cell carcinoma

Conditions

Interventions

OTHER

patients with renal cell carcinoma

Chemokines that may be elevated in patients with RCC

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • Avi Stein, M.D. · Carmel Medical Center

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02022787 on ClinicalTrials.gov